Pfizer offers full portfolio on not-for-profit basis to low-income countries 25-Jan-2023 By Ben Hargreaves The company confirms that its ‘An Accord for a Healthier World’ initiative will be rolled out to 45 lower-income countries.
Sun Pharma spends $576m to get hands on hair loss drug 24-Jan-2023 By Ben Hargreaves The Indian company decides to purchase Concert Pharmaceuticals, which is developing deuruxolitinib as a potential treatment for alopecia areata.
DIA Annual Meeting 2021 DIA 2021 will explore the potential of RNA based therapeutics 17-Jun-2021 By Jane Byrne In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.
